Advanced search
Publication Cover
Climacteric Volume 19, 2016 - Issue 5
Submit an article Journal homepage
412
Views
15
CrossRef citations to date
0
Altmetric
Original Article

The use of proton pump inhibitors is positively associated with osteoporosis in postmenopausal women in Germany

L. JacobDepartment of Biology, École Normale Supérieure de Lyon, Lyon, France;
,
P. HadjiDepartment of Bone Oncology, Endocrinology and Reproductive Medicine, Nordwest Hospital Frankfurt, Germany;
&
K. KostevIMS Health, Real World Evidence Solutions, Frankfurt, GermanyCorrespondence[email protected]
Pages 478-481 | Received 29 Mar 2016, Accepted 06 Jun 2016, Published online: 29 Jun 2016

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Brian Godman & Joseph Fadare. (2017) Non-guideline-recommended prescribing of proton pump inhibitors: implications for the future and reducing over usage. Current Medical Research and Opinion 33:11, pages 2085-2087.
Read now
Peyman Hadji, Louis Jacob & Karel Kostev. (2016) Gender- and age-related treatment compliance in patients with osteoporosis in Germany. Patient Preference and Adherence 10, pages 2379-2385.
Read now

Articles from other publishers (13)

Tao Han, Yili Zhang, Baoyu Qi, Ming Chen, Kai Sun, Xiaokuan Qin, Bowen Yang, He Yin, Aili Xu, Xu Wei & Liguo Zhu. (2023) Clinical features and shared mechanisms of chronic gastritis and osteoporosis. Scientific Reports 13:1.
Crossref
Johanna C Meyer, Sean MacBride-Stewart, Joseph O Fadare, Ammar Abdulrahman Jairoun, Mainul Haque, Amos Massele, Santosh Kumar, Israel Abebrese Sefah, Phumzile P Skosana & Brian Godman. (2022) Key Considerations From a Health Authority Perspective When Proton Pump Inhibitors Are Used to Treat Gastroesophageal Reflux Disease (GERD) and Their Implications. Cureus.
Crossref
Daniela Merlotti, Christian Mingiano, Roberto Valenti, Guido Cavati, Marco Calabrese, Filippo Pirrotta, Simone Bianciardi, Alberto Palazzuoli & Luigi Gennari. (2022) Bone Fragility in Gastrointestinal Disorders. International Journal of Molecular Sciences 23:5, pages 2713.
Crossref
L. A. Fomina, M. P. Fomina & V. V. Chernin. (2021) Hypercalcemia as a marker of decreased bone mineral density in patients with peptic ulcer disease. Experimental and Clinical Gastroenterology:2, pages 65-71.
Crossref
Leon Fisher, Alexander Fisher & Paul N Smith. (2020) Helicobacter pylori Related Diseases and Osteoporotic Fractures (Narrative Review). Journal of Clinical Medicine 9:10, pages 3253.
Crossref
L. A. Fomina, V. V. Chernin & M. P. Fomina. (2020) Comorbidity of peptic ulcer disease and osteoporosis in aspect of calcium regulatory system. Medical alphabet:10, pages 18-21.
Crossref
Rudolf W. Gasser. (2020) Protonenpumpeninhibitoren und OsteoporoserisikoProton pump inhibitors and risk of osteoporosis. Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen 27:1, pages 2-7.
Crossref
Nele Brusselaers, Omid Sadr-Azodi & Lars Engstrand. (2019) Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden. Journal of Gastroenterology 55:4, pages 453-461.
Crossref
E. Nowbahari, A. Bigot, F. Maillot, D. Antier & L. Foucault-Fruchard. (2020) Reassessment of inappropriate prescriptions of proton pump inhibitors in elderly in-patients: It's time to take action. Annales Pharmaceutiques Françaises 78:2, pages 150-157.
Crossref
Jian Liu, Xianqing Li, Lei Fan, Jie Yang, Jiecong Wang, Jiaming Sun & Zhenxing Wang. (2019) Proton pump inhibitors therapy and risk of bone diseases: An update meta-analysis. Life Sciences 218, pages 213-223.
Crossref
Agnes Czibulka. 2019. Laryngopharyngeal Reflux Disease. Laryngopharyngeal Reflux Disease 103 113 .
Scott C. Wagner. (2018) Proton Pump Inhibitors and Bone Health. JBJS Reviews 6:12, pages e6-e6.
Crossref
Karel Kostev, Peyman Hadji & Louis Jacob. (2018) Impact of Osteoporosis on the Risk of Dementia in Almost 60,000 Patients Followed in General Practices in Germany. Journal of Alzheimer's Disease 65:2, pages 401-407.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.